Individuals at high risk of developing seropositive rheumatoid arthritis (RA) can be identified
for translational research and disease prevention studies through the presence of highly …

Rheumatoid arthritis is the most commonly diagnosed systemic inflammatory arthritis.
Women, smokers, and those with a family history of the disease are most often affected …

Objective To develop evidence-based recommendations on the use of imaging of the joints
in the clinical management of rheumatoid arthritis (RA). Methods The task force comprised …

Autoimmune responses against posttranslationally modified antigens are a hallmark of
several autoimmune diseases. For example, antibodies against citrullinated protein antigens …

Rheumatoid arthritis (RA) is a prototypical autoimmune arthritis affecting nearly 1% of the
world population and is a significant cause of worldwide disability. Though prior studies …

Objective During the last decade, rheumatologists have learned to initiate disease‐
modifying antirheumatic drugs (DMARDs) early to improve the outcome of rheumatoid …

Objectives To monitor progression to inflammatory arthritis (IA) in individuals with non-
specific musculoskeletal (MSK) symptoms and positive anticyclic citrullinated peptide (anti …

Objective New criteria to classify rheumatoid arthritis (RA) have been derived in order to
increase the specificity and sensitivity for early RA compared with the 1987 American …

Objective To determine whether patients with undifferentiated arthritis (UA; inflammatory,
nontraumatic arthritis that cannot be diagnosed using current classification criteria) benefit …

Objectives. In order to allow personalized medicine, adequate prediction of disease
outcome is required. In early undifferentiated arthritis (UA), prediction of the development of …